Alnylam制药2024年第四季度调整后每股收益$0.06,销售额$5.93166亿超预期$5.83791亿

财报速递
13 Feb
Alnylam制药公布2024年第四季度财报,调整后每股收益为$0.06,销售额达到$5.93166亿,超出分析师预期的$5.83791亿。

以上内容来自Benzinga Earnings专栏,原文如下:

Alnylam Pharmaceuticals Q4 2024 Adj. EPS $0.06, Sales $593.166M Beat $583.791M Estimate

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10